These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19714675)

  • 21. Synthesis of 6-substituted 1-phenylbenzazepines and their dopamine D(1) receptor activities.
    Zhang J; Chen X; Yu L; Zhen X; Zhang A
    Bioorg Med Chem; 2008 Nov; 16(21):9425-31. PubMed ID: 18835172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isomeric thiazole derivatives as ligands for the neuropeptide Y5 receptor.
    Nettekoven M; Guba W; Neidhart W; Mattei P; Pflieger P; Roche O; Taylor S
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3446-9. PubMed ID: 15951170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aporphine enantiomers. Interactions with D-1 and D-2 dopamine receptors.
    Goldman ME; Kebabian JW
    Mol Pharmacol; 1984 Jan; 25(1):18-23. PubMed ID: 6231468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parallel synthesis and biological screening of dopamine receptor ligands taking advantage of a click chemistry based BAL linker.
    Bettinetti L; Löber S; Hübner H; Gmeiner P
    J Comb Chem; 2005; 7(2):309-16. PubMed ID: 15762761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands.
    Ortega R; Raviña E; Masaguer CF; Areias F; Brea J; Loza MI; López L; Selent J; Pastor M; Sanz F
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1773-8. PubMed ID: 19217777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel synthesis and pharmacological evaluation of a potential dopamine D1/D2 agonist: 1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline-6,7-diol.
    Liu D; Dijkstra D; de Vries JB; Wikström HV
    Bioorg Med Chem; 2008 Mar; 16(6):3438-44. PubMed ID: 18313303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and evaluation of potent and selective ligands for the dopamine 3 (D3) receptor with a novel in vivo behavioral profile.
    Chen J; Collins GT; Zhang J; Yang CY; Levant B; Woods J; Wang S
    J Med Chem; 2008 Oct; 51(19):5905-8. PubMed ID: 18785726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of 3-aryl piperidine analogs as potent and efficacious dopamine D4 receptor agonists.
    Wang X; Bhatia PA; Daanen JF; Latsaw SP; Rohde J; Kolasa T; Hakeem AA; Matulenko MA; Nakane M; Uchic ME; Miller LN; Chang R; Moreland RB; Brioni JD; Stewart AO
    Bioorg Med Chem; 2005 Aug; 13(15):4667-78. PubMed ID: 15896964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extremely potent orally active benzo[g]quinoline analogue of the dopaminergic prodrug: 1-propyl-trans-2,3,4,4a,5,7,8,9,10,10a-decahydro-1H-benzo-[g]quinolin-6-one [corrected].
    Liu D; Wikström HV; Dijkstra D; de Vries JB; Venhuis BJ
    J Med Chem; 2006 Feb; 49(4):1494-8. PubMed ID: 16480286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and synthesis of a functionally selective D3 agonist and its in vivo delivery via the intranasal route.
    Blagg J; Allerton CM; Batchelor DV; Baxter AD; Burring DJ; Carr CL; Cook AS; Nichols CL; Phipps J; Sanderson VG; Verrier H; Wong S
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6691-6. PubMed ID: 17976986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and dopamine receptor affinities of N-alkyl-11-hydroxy-2-methoxynoraporphines: N-alkyl substituents determine D1 versus D2 receptor selectivity.
    Si YG; Gardner MP; Tarazi FI; Baldessarini RJ; Neumeyer JL
    J Med Chem; 2008 Feb; 51(4):983-7. PubMed ID: 18251489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New N-n-propyl-substituted 3-aryl- and 3-cyclohexylpiperidines as partial agonists at the D4 dopamine receptor.
    Macchia M; Cervetto L; Demontis GC; Longoni B; Minutolo F; Orlandini E; Ortore G; Papi C; Sbrana A; Macchia B
    J Med Chem; 2003 Jan; 46(1):161-8. PubMed ID: 12502370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrostatic surface potential calculation on several new halogenated benzimidazole-like dopaminergic ligands.
    Sukalović V; Andrić D; Roglić G; Kostić-Rajaccić S; Soskić V
    Arch Pharm (Weinheim); 2004 Jul; 337(7):376-82. PubMed ID: 15237387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective agonists for dopamine/neurotensin receptor heterodimers.
    Koschatzky S; Gmeiner P
    ChemMedChem; 2012 Mar; 7(3):509-14. PubMed ID: 22213714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G protein coupling and ligand selectivity of the D2L and D3 dopamine receptors.
    Lane JR; Powney B; Wise A; Rees S; Milligan G
    J Pharmacol Exp Ther; 2008 Apr; 325(1):319-30. PubMed ID: 18218829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular evolution of adrenoceptors and dopamine receptors: implications for the binding of catecholamines.
    Xhaard H; Rantanen VV; Nyrönen T; Johnson MS
    J Med Chem; 2006 Mar; 49(5):1706-19. PubMed ID: 16509586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indoloquinolizidine-peptide hybrids as multiple agonists for D1 and D2 dopamine receptors.
    Vendrell M; Soriano A; Casadó V; Díaz JL; Lavilla R; Canela EI; Lluís C; Franco R; Albericio F; Royo M
    ChemMedChem; 2009 Sep; 4(9):1514-22. PubMed ID: 19557804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, pharmacological evaluation and molecular modeling studies of triazole containing dopamine D3 receptor ligands.
    Peng X; Wang Q; Mishra Y; Xu J; Reichert DE; Malik M; Taylor M; Luedtke RR; Mach RH
    Bioorg Med Chem Lett; 2015 Feb; 25(3):519-23. PubMed ID: 25556097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functionally selective dopamine D2/D3 receptor agonists comprising an enyne moiety.
    Hiller C; Kling RC; Heinemann FW; Meyer K; Hübner H; Gmeiner P
    J Med Chem; 2013 Jun; 56(12):5130-41. PubMed ID: 23730937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and structure-activity relationship studies of hexahydropyrazinoquinolines as a novel class of potent and selective dopamine receptor 3 (D3) ligands.
    Ji M; Chen J; Ding K; Wu X; Varady J; Levant B; Wang S
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1701-5. PubMed ID: 15745825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.